Skip to main content
Erschienen in: International Journal of Clinical Oncology 3/2015

01.06.2015 | Original Article

Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway

verfasst von: Qingquan Luo, Hao Lin, Xiangyun Ye, Jia Huang, Shun Lu, Lin Xu

Erschienen in: International Journal of Clinical Oncology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Trim44 is an important member of the tripartite motif-containing protein (TRIM) family. Recent research reported that Trim44 might play an important role in tumorigenesis, although its role in non-small cell lung cancer (NSCLC) and the related mechanisms is not yet known.

Methods

In this study we analyzed 30 pairs of NSCLC tumors and the matched adjacent normal tissue to define the relationship between Trim44 and NSCLC tumors. The function of Trim44 in cell migration and invasion was determined by overexpression of Trim44 in normal bronchial epithelial cell line 16HE or knockdown of Trim44 in A549 cells, respectively. Whether Trim44-mediated NF-κB signaling activation was involved in Trim44-mediated promotion of lung cancer was tested by q-PCR analysis and cell migration and invasion assay using PDTC, an inhibitor of NF-κB.

Results

We found that Trim44 was upregulated in NSCLC tumors (14/30 cases; 46.7 %). Furthermore, Trim44 was upregulated in many NSCLC cell lines, especially in A549 and H441. Moreover, Trim44 significantly enhanced cell migration and invasion ability, which was related to increased CXCR6 and matrix metalloproteinase 9 (MMP9). Knockdown of Trim44 in A549 cells by siRNA showed a diminished effect in cell migration and invasion. Further investigation revealed that blocking the NF-κB signaling pathway using PDTC, an inhibitor of NF-κB, reversed the expression of CXCR6 and MMP9, and alleviated the promotion of migration and invasion mediated by Trim44.

Conclusions

Our data suggest that Trim44 promotes NSCLC development through activation of NF-κB signaling via upregulating CXCL16 and MMP9 expression.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM et al (2011) Global cancer statistics CA. Cancer J Clin 61:69–90CrossRef Jemal A, Bray F, Center MM et al (2011) Global cancer statistics CA. Cancer J Clin 61:69–90CrossRef
2.
Zurück zum Zitat Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150PubMedCrossRef Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150PubMedCrossRef
4.
Zurück zum Zitat McNab FW, Rajsbaum R, Stoye JP et al (2011) Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 23:46–56PubMedCrossRef McNab FW, Rajsbaum R, Stoye JP et al (2011) Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 23:46–56PubMedCrossRef
6.
Zurück zum Zitat Jefferies C, Wynne C, Higgs R (2011) Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat Rev Immunol 11:617–625PubMedCrossRef Jefferies C, Wynne C, Higgs R (2011) Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat Rev Immunol 11:617–625PubMedCrossRef
7.
Zurück zum Zitat Li Q, Yan J, Mao AP et al (2011) Tripartite motif 8 (TRIM8) modulates TNFalpha- and IL-1beta-triggered NF-kappaB activation by targeting TAK1 for K63-linked polyubiquitination. Proc Natl Acad Sci USA 108:19341–19346PubMedCentralPubMedCrossRef Li Q, Yan J, Mao AP et al (2011) Tripartite motif 8 (TRIM8) modulates TNFalpha- and IL-1beta-triggered NF-kappaB activation by targeting TAK1 for K63-linked polyubiquitination. Proc Natl Acad Sci USA 108:19341–19346PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Nisole S, Stoye JP, Saib A (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3:799–808PubMedCrossRef Nisole S, Stoye JP, Saib A (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3:799–808PubMedCrossRef
9.
Zurück zum Zitat Bieniasz PD (2004) Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 5:1109–1115PubMedCrossRef Bieniasz PD (2004) Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 5:1109–1115PubMedCrossRef
10.
Zurück zum Zitat Yang K, Shi HX, Liu XY et al (2009) TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol 182:3782–3792PubMedCrossRef Yang K, Shi HX, Liu XY et al (2009) TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol 182:3782–3792PubMedCrossRef
11.
Zurück zum Zitat Boutou E, Matsas R, Mamalaki A (2001) Isolation of a mouse brain cDNA expressed in developing neuroblasts and mature neurons. Brain Res Mol Brain Res 86:153–167PubMedCrossRef Boutou E, Matsas R, Mamalaki A (2001) Isolation of a mouse brain cDNA expressed in developing neuroblasts and mature neurons. Brain Res Mol Brain Res 86:153–167PubMedCrossRef
12.
Zurück zum Zitat Yang B, Wang J, Wang Y (2013) Novel function of Trim44 promotes an antiviral response by stabilizing VISA. J Immunol 190:3613–3619PubMedCrossRef Yang B, Wang J, Wang Y (2013) Novel function of Trim44 promotes an antiviral response by stabilizing VISA. J Immunol 190:3613–3619PubMedCrossRef
13.
Zurück zum Zitat Peters CJ, Rees JR, Hardwick RH et al (2010) A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology 139(e1915):1995–2004PubMedCrossRef Peters CJ, Rees JR, Hardwick RH et al (2010) A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology 139(e1915):1995–2004PubMedCrossRef
14.
Zurück zum Zitat Jarvinen AK, Autio R, Kilpinen S et al (2008) High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosom Cancer 47:500–509PubMedCrossRef Jarvinen AK, Autio R, Kilpinen S et al (2008) High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosom Cancer 47:500–509PubMedCrossRef
15.
Zurück zum Zitat Kashimoto K, Komatsu S, Ichikawa D et al (2012) Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma. Cancer Sci 103:2021–2026PubMedCrossRef Kashimoto K, Komatsu S, Ichikawa D et al (2012) Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma. Cancer Sci 103:2021–2026PubMedCrossRef
16.
Zurück zum Zitat Hu Y, Wang J, Yang B (2011) Guanylate binding protein 4 negatively regulates virus-induced type I IFN and antiviral response by targeting IFN regulatory factor 7. J Immunol 187:6456–6462PubMedCrossRef Hu Y, Wang J, Yang B (2011) Guanylate binding protein 4 negatively regulates virus-induced type I IFN and antiviral response by targeting IFN regulatory factor 7. J Immunol 187:6456–6462PubMedCrossRef
17.
Zurück zum Zitat Beck G, Yard BA, Schulte J et al (2003) Secreted phospholipases A2 induce the expression of chemokines in microvascular endothelium. Biochem Biophys Res Commun 300:731–737PubMedCrossRef Beck G, Yard BA, Schulte J et al (2003) Secreted phospholipases A2 induce the expression of chemokines in microvascular endothelium. Biochem Biophys Res Commun 300:731–737PubMedCrossRef
18.
Zurück zum Zitat Chen L, Chen DT, Kurtyka C et al (2012) Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions. J Biol Chem 287:40106–40118PubMedCentralPubMedCrossRef Chen L, Chen DT, Kurtyka C et al (2012) Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions. J Biol Chem 287:40106–40118PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Zhou ZY, Yang GY, Zhou J et al (2012) Significance of TRIM29 and beta-catenin expression in non-small-cell lung cancer. J Chin Med Assoc 75:269–274PubMedCrossRef Zhou ZY, Yang GY, Zhou J et al (2012) Significance of TRIM29 and beta-catenin expression in non-small-cell lung cancer. J Chin Med Assoc 75:269–274PubMedCrossRef
20.
Zurück zum Zitat Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327–336PubMedCrossRef Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327–336PubMedCrossRef
21.
Zurück zum Zitat Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science (New York) 285:1028–1032CrossRef Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science (New York) 285:1028–1032CrossRef
22.
Zurück zum Zitat Stetler-Stevenson WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9:289–303PubMedCrossRef Stetler-Stevenson WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9:289–303PubMedCrossRef
23.
Zurück zum Zitat Zeng ZS, Cohen AM, Guillem JG (1999) Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 20:749–755PubMedCrossRef Zeng ZS, Cohen AM, Guillem JG (1999) Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 20:749–755PubMedCrossRef
24.
Zurück zum Zitat Papathoma AS, Zoumpourlis V, Balmain A et al (2001) Role of matrix metalloproteinase-9 in progression of mouse skin carcinogenesis. Mol Carcinog 31:74–82PubMedCrossRef Papathoma AS, Zoumpourlis V, Balmain A et al (2001) Role of matrix metalloproteinase-9 in progression of mouse skin carcinogenesis. Mol Carcinog 31:74–82PubMedCrossRef
25.
Zurück zum Zitat Cockett MI, Murphy G, Birch ML et al (1998) Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp 63:295–313PubMed Cockett MI, Murphy G, Birch ML et al (1998) Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp 63:295–313PubMed
26.
Zurück zum Zitat Bianco FJ Jr, Gervasi DC, Tiguert R et al (1998) Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade. Clin Cancer Res 4:3011–3016PubMed Bianco FJ Jr, Gervasi DC, Tiguert R et al (1998) Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade. Clin Cancer Res 4:3011–3016PubMed
27.
Zurück zum Zitat Lee JM, Dedhar S, Kalluri R et al (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973–981PubMedCentralPubMedCrossRef Lee JM, Dedhar S, Kalluri R et al (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973–981PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Tsuruta D (2009) NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov 3:40–48PubMedCrossRef Tsuruta D (2009) NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov 3:40–48PubMedCrossRef
29.
Zurück zum Zitat Wang S, Uchi H, Hayashida S et al (2009) Differential expression of phosphorylated extracellular signal-regulated kinase 1/2, phosphorylated p38 mitogen-activated protein kinase and nuclear factor-kappaB p105/p50 in chronic inflammatory skin diseases. J Dermatol 36:534–540PubMedCrossRef Wang S, Uchi H, Hayashida S et al (2009) Differential expression of phosphorylated extracellular signal-regulated kinase 1/2, phosphorylated p38 mitogen-activated protein kinase and nuclear factor-kappaB p105/p50 in chronic inflammatory skin diseases. J Dermatol 36:534–540PubMedCrossRef
Metadaten
Titel
Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway
verfasst von
Qingquan Luo
Hao Lin
Xiangyun Ye
Jia Huang
Shun Lu
Lin Xu
Publikationsdatum
01.06.2015
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 3/2015
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-014-0752-9

Weitere Artikel der Ausgabe 3/2015

International Journal of Clinical Oncology 3/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.